Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Measurement of cumulative high-sensitivity C-reactive protein and monocyte to high-density lipoprotein ratio in the risk prediction of type 2 diabetes: a prospective cohort study

Fig. 2

Cumulative incidence of type 2 diabetes across CumCRP-by-CumMHR strata. G1 CumCRP < 1 mg/L & CumMHR < 0.2340; G2 1 ≤ CumCRP < 3 mg/L & CumMHR < 0.2340; G3 CumCRP ≥ 3 mg/L & CumMHR < 0.2340; G4 CumCRP < 1 mg/L & CumMHR ≥ 0.2340; G5 1 ≤ CumCRP < 3 mg/L & CumMHR ≥ 0.2340; G6 CumCRP ≥ 3 mg/L & CumMHR ≥ 0.2340. Kaplan–Meier curves demonstrating the cumulative incidence and number at risk of diabetes across CumCRP-by-CumMHR subgroups in the entire population; No. at risk indicates the number of participants at specified time intervals with partially censored data

Back to article page